A novel GSK3β inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease

This publication has 44 references indexed in Scilit:

• Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity
  European Journal of Medicinal Chemistry, 2025
• A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease
  Cell Stem Cell, 2023
• An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease
  Neuropharmacology, 2023
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
  Cell, 2019
• It’s all about tau
  Progress in Neurobiology, 2019
• Neuroinflammation in Alzheimer's disease: Current evidence and future directions
  Alzheimer's & Dementia, 2016
• Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application
  Molecular Neurobiology, 2014
• Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice
  European Journal of Pharmacology, 2013
• GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
  Neurochemistry International, 2012
• A Chaperone-Dependent GSK3β Transitional Intermediate Mediates Activation-Loop Autophosphorylation
  Molecular Cell, 2006